AAM
IDXX icon

Ardevora Asset Management’s Idexx Laboratories IDXX Stock Holding History

Ardevora Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$6.04M Sell
10,883
-12,011
-52% -$5.64M 0.54% 77
2023
Q3 		$10M Sell
22,894
-17,552
-43% -$8.75M 0.49% 84
2023
Q2 		$20.3M Sell
40,446
-63,121
-61% -$30.2M 0.49% 72
2023
Q1 		$51.8M Sell
103,567
-10,128
-9% -$4.85M 0.93% 48
2022
Q4 		$46.4M Buy
+113,695
New +$44.1M 0.79% 48
2021
Q4 		– Sell
-1,100
Closed -$684K – 146
2021
Q3 		$684K Sell
1,100
-200
-15% -$134K 0.01% 125
2021
Q2 		$821K Buy
1,300
+500
+63% +$276K 0.01% 117
2021
Q1 		$391K Sell
800
-101,940
-99% -$51.1M 0.01% 128
2020
Q4 		$51.4M Sell
102,740
-24,800
-19% -$11.1M 0.79% 92
2020
Q3 		$50.1M Buy
127,540
+400
+0.3% +$148K 0.92% 58
2020
Q2 		$42M Sell
127,140
-31,960
-20% -$9.25M 0.82% 88
2020
Q1 		$38.5M Sell
159,100
-7,000
-4% -$1.83M 1.02% 44
2019
Q4 		$43.4M Buy
166,100
+49,900
+43% +$13.1M 0.97% 77
2019
Q3 		$31.6M Sell
116,200
-10,900
-9% -$3.03M 0.88% 86
2019
Q2 		$35M Buy
+127,100
New +$31.3M 0.86% 71
2018
Q3 		– Sell
-158,120
Closed -$34.5M – 123
2018
Q2 		$34.5M Buy
+158,120
New +$32.6M 0.97% 35
2017
Q3 		– Sell
-238,400
Closed -$38.5M – 107
2017
Q2 		$38.5M Sell
238,400
-21,000
-8% -$3.41M 1.21% 12
2017
Q1 		$40.1M Buy
259,400
+20,400
+9% +$2.81M 1.32% 1
2016
Q4 		$28M Sell
239,000
-18,100
-7% -$2.07M 1% 34
2016
Q3 		$29M Sell
257,100
-52,300
-17% -$5.51M 1.07% 45
2016
Q2 		$28.7M Sell
309,400
-1,600
-0.5% -$137K 1.2% 27
2016
Q1 		$24.4M Sell
311,000
-5,200
-2% -$374K 1.19% 39
2015
Q4 		$23.1M Buy
316,200
+153,400
+94% +$10.9M 1.52% 4
2015
Q3 		$12.1M Buy
162,800
+38,500
+31% +$2.76M 1.76% 2
2015
Q2 		$7.97M Buy
124,300
+17,700
+17% +$1.23M 1.38% 33
2015
Q1 		$8.23M Buy
+106,600
New +$8.3M 1.56% 9

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ardevora Asset Management's IDXX Position: Q4 2023 in Review

Ardevora Asset Management reduced its Idexx Laboratories (IDXX) stake by 52% in Q4 2023, selling an estimated $5.64M and leaving 10,883 shares worth $6.04M. The position accounts for 0.54% of the portfolio, ranked #77.

Ardevora Asset Management first reported a position in IDXX in Q1 2015 and has held it in 26 quarters since. The position peaked at $51.8M in Q1 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Ardevora Asset Management held 10,883 shares of Idexx Laboratories worth $6.04M as of Q4 2023.
  • Ardevora Asset Management sold 12,011 Idexx Laboratories shares in Q4 2023, an estimated $5.64M.
  • Idexx Laboratories made up 0.54% of Ardevora Asset Management's portfolio in Q4 2023, its #77 holding.
  • Ardevora Asset Management first reported a position in Idexx Laboratories in Q1 2015 and has held it in 26 quarters since.
  • Ardevora Asset Management's Idexx Laboratories position peaked at $51.8M in Q1 2023.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.